- Home
- CPBI vs MAIA Comparison
CPBI vs MAIA Comparison
Compare CPBI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- MAIA
- Stock Information
- Founded
- CPBI 2023
- MAIA 2018
- Country
- CPBI United States
- MAIA United States
- Employees
- CPBI N/A
- MAIA N/A
- Industry
- CPBI
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- MAIA Health Care
- Exchange
- CPBI Nasdaq
- MAIA Nasdaq
- Market Cap
- CPBI 56.9M
- MAIA 46.7M
- IPO Year
- CPBI N/A
- MAIA 2022
- Fundamental
- Price
- CPBI $15.05
- MAIA $1.79
- Analyst Decision
- CPBI
- MAIA
- Analyst Count
- CPBI 0
- MAIA 0
- Target Price
- CPBI N/A
- MAIA N/A
- AVG Volume (30 Days)
- CPBI 4.2K
- MAIA 402.9K
- Earning Date
- CPBI 01-01-0001
- MAIA 08-08-2025
- Dividend Yield
- CPBI N/A
- MAIA N/A
- EPS Growth
- CPBI 29.70
- MAIA N/A
- EPS
- CPBI 1.62
- MAIA N/A
- Revenue
- CPBI $18,546,000.00
- MAIA N/A
- Revenue This Year
- CPBI N/A
- MAIA N/A
- Revenue Next Year
- CPBI N/A
- MAIA N/A
- P/E Ratio
- CPBI $9.31
- MAIA N/A
- Revenue Growth
- CPBI 13.73
- MAIA N/A
- 52 Week Low
- CPBI $9.99
- MAIA $1.40
- 52 Week High
- CPBI $15.50
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- CPBI 60.83
- MAIA 47.69
- Support Level
- CPBI $14.85
- MAIA $1.66
- Resistance Level
- CPBI $14.99
- MAIA $1.95
- Average True Range (ATR)
- CPBI 0.09
- MAIA 0.10
- MACD
- CPBI 0.04
- MAIA -0.00
- Stochastic Oscillator
- CPBI 100.00
- MAIA 23.28
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.